Andere Sprachen Elutia Inc.

Aktien

A2QD87

US05479K1060

ELUT

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 15.05.2024			% 5 Tage	% 1. Jan.
3,28 ^USD	-1,80 %		+12,33 %	+51,85 %

09.05.	Elutia Inc. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI
09.05.	Transcript : Elutia Inc., Q1 2024 Earnings Call, May 09, 2024

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024	13.05.
Elutia Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09.05.
Elutia : Q1 2024 Financial Results Presentation	09.05.
Earnings Flash (ELUT) ELUTIA Posts Q1 Revenue $6.7M, vs. Street Est of $6.1M	09.05.
Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance	09.05.
Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024	02.05.
Elutia Planet MicroCap Showcase: VEGAS 2024 Presentation	02.05.
Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1	24.04.
Elutia Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	07.03.
Elutia Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	07.03.
Earnings Flash (ELUT) ELUTIA Posts Q4 Revenue $5.9M, vs. Street Est of $6.6M	07.03.
Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024	07.03.
Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024	22.02.
Elutia's CanGarooRM: Pioneering Drug-Eluting Biologic for Secure Medical Implants	20.02.
Elutia Regains Compliance with Nasdaq Listing Requirements	10.01.
Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance	18.12.
Elutia Submits CanGaroo Antibiotic-Eluting Biomatrix for FDA Clearance	18.12.
Elutia : The Wall Street Transcript	05.12.
Elutia Inc. Amendments to Credit Agreement with SWK Funding LLC	15.11.
Elutia Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Elutia Inc.

Aktien

A2QD87

US05479K1060

ELUT

Andere Sprachen

Filter